Polpharma API
Our flexible cooperation models enable us to meet the specific needs of our partners. By collaborating closely with others in the pharmaceutical sector, we achieve shared successes and provide innovative, effective therapies for patients. Together, we are dedicated to advancing healthcare through strong partnerships.
- Contract Development and Manufacturing (CDMO): We work with partners throughout development and manufacturing, participating in the full product lifecycle, from idea to launch.
- Supplies of APIs from our own development: We supply substances that we have developed ourselves, in accordance with our quality standards.
- Co-development: We are happy to engage in the joint development of new substances, which allows for the sharing of knowledge and experience, as well as for faster introduction of innovations to the market.
- Contract Manufacturing (CMO): We offer manufacturing services to other companies, which can be beneficial if they need manufacturing support but still want to focus on other aspects of their business.
Why partnerig with Polpharma API?
Capabilities
Broad type of technologies with end-to-end solutions from process development to large-scale production
Global reach
FDA-approved plant located in Central Europe with presence on +70 markets around the world
Fast execution
Fully integrated Business Unit, from R&D, IO, Supply Chain to Commercial with fast-decision making
Key numbers
Regulatory Filings
We manufacture our products in strict accordance with the highest standards
set by our customers and health authorities. Our DMF documentation for all products is prepared to comply with the latest regulations: EDQM (CEP), ICH (EU DMF, CTD), and FDA (US DMF). Furthermore, all material and product testing is conducted in alignment with the European and United States Pharmacopeias,
ensuring the utmost quality and compliance.
API Manufacturing Sites
We are the largest Polish manufacturer of active pharmaceutical ingredients. Our substances are available in over 60 countries on six continents. We employ the latest technologies to ensure the safety of our products, protect our employees, and safeguard the natural environment.
Starogard Gdanski Site
(tank farm and solid raw materials)
R&D Laboratories
Polpharma FDF
- Administration
- Adm. & Training Center
- R&D and QC Laboratory (Pharma & API)
- Finish Dosage Form Plant
- High Bay Warehouse
- Glass Production Site
- Polyethylene Production Site
API BU
- PS1-Hall 10/11
- PS2-Hall 26
- PS3-Hall 27
- PS4-Hall 17
- PS4-Hall 22
- PS5-Hall 28
- PP-Pilot Plant
- SRM-Solid Raw Materials Warehouse
- TF-Tank Farm
- QC1-”Wet Lab”
- QC2-Instrumental Lab
- UR-Workshop
- HP API Facility
- Photovoltaic Farm
Manufacturing plant
With reactor volume from 150 L to 6 000 L in 6 interconnected buildings, operating from -50°C to +200°C pressure up to 10 bar, and highly automated units for reaction parameters monitoring and control, we are being positioned among top European API CDMOs. We can accommodate a broad range of chemical processes to support customers in contract development and contract manufacturing projects.
Segregated clean areas with a different types of equipment for isolation (nutch filters, centrifuges) and drying (filter driers, tray driers, vacuum driers). Milling and micronization to adapt particle size distribution to required customer needs.